Changing of the guard at PDMA Alliance

Lisa A. Butler, newly elected president of the PDMA Alliance, has been an Alliance Board Member for the past three years. She is an associate director of DEA/PDMA Compliance for Novartis Business Services. For the last 25 years, she has […]

Read More

FDA streamlines its ‘compassionate use’ process

The possibility that an investigational drug, not yet approved for commercial use, could be life-saving to some patients has been an ongoing dilemma for industry and for healthcare providers (HCPs). On the one hand, desperate patients, sensing that such a […]

Read More